Allchem Lifescience Limited*, an Indian manufacturer of active pharmaceutical ingredients (API) intermediates and speciality chemicals, has received SEBI approval for their IPO
The IPO comprises of a fresh issue of equity shares of face value of ₹10 each aggregating up
